Vinblastine is a chemotherapy medication used to treat various types of cancer, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, and Kaposi’s sarcoma. It belongs to the class of drugs known as vinca alkaloids and works by inhibiting microtubule formation in the mitotic spindle, thereby preventing cell division and leading to cancer cell death. It is grouped under the following drug class(es): Microtubule inhibitors and Vinca alkaloids. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Rozevin, Velbe and Vinblastina lilly. Its PubChem CID is 13342.
Vinblastine
| CAS No | 865-21-4 |
|---|---|
| Molecular Formula | C46H58N4O9 |
| Molecular Weight | 811.0 g/mol |
| Synonyms | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vinblastine is a chemotherapy medication used to treat various types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and Kaposi's sarcoma.
The listed CAS number is 865-21-4.
The listed molecular formula is C46H58N4O9.
The listed molecular weight is 811.0 g/mol.
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate.
The source lists Rozevin, Velbe and Vinblastina lilly.